A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT05183139 · WITHDRAWN

Trial details

NCT number: NCT05183139
Sponsor: Takeda
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2022-06-30
Primary completion: 2026-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.